These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22514377)

  • 1. Antimicrobial activity of ceftriaxone compared with cefotaxime in the presence of serum albumin.
    Nath SK; Foster GA; Mandell LA; Rotstein C
    Can J Infect Dis; 1995 Jan; 6(1):21-7. PubMed ID: 22514377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.
    Jones RN; Barry AL
    Antimicrob Agents Chemother; 1987 May; 31(5):818-20. PubMed ID: 3606081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MICs and MBCs of cefotaxime, desacetylcefotaxime and ceftriaxone against four principal bacteria causing meningitis].
    Deguchi K; Fukuyama S; Nishimura Y; Nishike A; Fukumoto T; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N
    Jpn J Antibiot; 1984 Sep; 37(9):1701-13. PubMed ID: 6096585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the influence of protein binding on serum bactericidal titres and killing rates in volunteers receiving ceftazidime, cefotaxime and ceftriaxone.
    Van der Auwera P; Klastersky J
    J Hosp Infect; 1990 Apr; 15 Suppl A():23-34. PubMed ID: 1971641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonistic effect of chloramphenicol in combination with cefotaxime or ceftriaxone.
    Asmar BI; Prainito M; Dajani AS
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1375-8. PubMed ID: 3195999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal cefotaxime dosing for gram-negative bacteremia: effective trough serum bactericidal titers and drug concentrations 8 and 12 hr after 1- or 2-gm infusions.
    Goodpasture HC; Gerlach EH; Jones RN; Peterie JD
    Diagn Microbiol Infect Dis; 1988 Feb; 9(2):97-103. PubMed ID: 3383550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bactericidal speed of ceftriaxone and cefotaxime on 18 strains of Haemophilus influenzae].
    Boisivon A; Bérardi-Grassias LD
    Pathol Biol (Paris); 1987 May; 35(5):521-2. PubMed ID: 3302854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae.
    Haas DW; Stratton CW; Griffin JP; Weeks L; Alls SC
    Clin Infect Dis; 1995 Mar; 20(3):671-6. PubMed ID: 7756494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ceftriaxone on Pseudomonas aeruginosa and Staphylococcus aureus in broth, serum, and in combination with human polymorphonuclear leukocytes.
    Bassler M; Blaschke H; Just M; Daschner FD
    Chemotherapy; 1982; 28(5):390-6. PubMed ID: 6291868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of ceftriaxone versus cefotaxime: negative effect of serum albumin binding of ceftriaxone.
    Nath SK; Foster GA; Mandell LA; Rotstein C
    J Antimicrob Chemother; 1994 Jun; 33(6):1239-43. PubMed ID: 7928818
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus].
    Vallée E; Joly-Guillou ML; Bergogne-Berezin E
    Presse Med; 1990 Apr; 19(13):588-91. PubMed ID: 2139937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone against gram-negative and gram-positive bacteria: bactericidal and post-antibiotic effect.
    Ravizzola G; Bonfanti C; Savoldi E; Turano A
    Chemioterapia; 1985 Jun; 4(3):204-8. PubMed ID: 3875430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review.
    Jones RN
    Diagn Microbiol Infect Dis; 1995; 22(1-2):19-33. PubMed ID: 7587039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the bactericidal activity of cefotaxime and desacetylcefotaxime alone and in combination against Bacteroides fragilis group organisms.
    Aldridge KE; Weeks LS; Stratton CW; Sanders CV
    Diagn Microbiol Infect Dis; 1989; 12(2):165-70. PubMed ID: 2752714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro activity of cefotaxime and desacetylcefotaxime alone and in combination against 320 gram-negative clinical isolates.
    Piédrola G; Galan I; Leyva A; Maroto MC
    Drugs; 1988; 35 Suppl 2():62-4. PubMed ID: 3135171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime.
    Regamey C
    Chemotherapy; 1985; 31(2):85-94. PubMed ID: 3987394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Resistance of Listeria monocytogenes to cefotaxime and ceftriaxone combined with an aminoside].
    Borderon E; Borderon JC; Feron JF; Thieffry JC; Tescher M; Farid IA
    Pathol Biol (Paris); 1987 May; 35(5):568-71. PubMed ID: 3112709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.
    Oizumi K; Hayashi I; Aonuma S; Konno K
    Drugs; 1988; 35 Suppl 2():57-61. PubMed ID: 3135170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi.
    Ates L; Hanssen-Hübner C; Norris DE; Richter D; Kraiczy P; Hunfeld KP
    Ticks Tick Borne Dis; 2010 Mar; 1(1):30-4. PubMed ID: 21771509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.